Table 2. Functional redundant activities between Nkx2.5 and Nkx2.7 in zebrafish heart development.
Morpholino (ng) | mRNA (pg) | Total (n) | Heart Defects (%) | ||
Nkx2.5 | Nkx2.7 | Nkx2.5 | Nkx2.7 | ||
0 | 9 ng | 0 | 0 | 177 | 55% |
0 | 9 ng | 10 pg | 0 | 109 | 32% |
0 | 9 ng | 20 pg | 0 | 113 | 22% |
8 ng | 8 ng | 0 | 0 | 146 | 91% |
8 ng | 8 ng | 25 pg | 0 | 278 | 73% |
8 ng | 8 ng | 50 pg | 0 | 169 | 58% |
8 ng | 8 ng | 0 | 0 | 166 | 92% |
8 ng | 8 ng | 0 | 0.25 pg | 189 | 61% |
8 ng | 8 ng | 0 | 0.5 pg | 206 | 43% |
For rescue study, the Nkx2.5 mRNA was co-injected with Nkx2.7-MO into embryos derived from zebrafish transgenic line Tg(cmlc2::GFP). The percentages of heart defects were decreased compared to phenotypes which occurred in the embryos injected with Nkx2.7-MO alone. Similarly, either the Nkx2.5 or Nkx2.7 mRNA enabled embryos to be rescued from the defects as a result of the injection of Nkx2.5/2.7-MO. n: total number of embryos analyzed.